|
TWI510246B
(zh)
|
2010-04-30 |
2015-12-01 |
Molecular Partners Ag |
抑制ｖｅｇｆ－ａ受體交互作用的經修飾結合性蛋白質
|
|
EP3514169B1
(en)
|
2010-11-26 |
2024-03-06 |
Molecular Partners AG |
Designed repeat proteins binding to serum albumin
|
|
PT2846836T
(pt)
|
2012-05-07 |
2019-10-29 |
Allergan Inc |
Método de tratamento de dmi em doentes refratários à terapia anti-vegf
|
|
SG11201408196RA
(en)
*
|
2012-06-28 |
2015-03-30 |
Molecular Partners Ag |
Designed ankyrin repeat proteins binding to platelet-derived growth factor
|
|
EP2906591A1
(en)
*
|
2012-10-15 |
2015-08-19 |
Universität Zürich |
Bispecific her2 ligands for cancer therapy
|
|
EP2738180A1
(en)
|
2012-11-30 |
2014-06-04 |
Molecular Partners AG |
Binding proteins comprising at least two binding domains against HER2.
|
|
WO2014131694A1
(en)
|
2013-02-26 |
2014-09-04 |
Roche Glycart Ag |
Bispecific t cell activating antigen binding molecules
|
|
US11453708B2
(en)
|
2013-05-31 |
2022-09-27 |
Molecular Partners Ag |
Designed ankyrin repeat proteins binding to hepatocyte growth factor
|
|
KR20150097304A
(ko)
|
2014-02-18 |
2015-08-26 |
삼성전자주식회사 |
항 EGFR DARPin을 포함하는 EGFR/HER2 이중 특이 항체
|
|
CN106605228B
(zh)
|
2014-07-07 |
2019-08-16 |
耶达研究及发展有限公司 |
计算蛋白质设计的方法
|
|
US9458211B1
(en)
*
|
2015-04-02 |
2016-10-04 |
Molecular Partners Ag |
Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains
|
|
MY196882A
(en)
|
2016-09-22 |
2023-05-08 |
Molecular Partners Ag |
Recombinant binding proteins and their use
|
|
AU2017354041B2
(en)
*
|
2016-11-01 |
2024-02-01 |
Arrowhead Pharmaceuticals, Inc. |
Alpha-V beta-6 integrin ligands and uses thereof
|
|
WO2018165046A1
(en)
|
2017-03-07 |
2018-09-13 |
Igc Bio, Inc. |
A computational pipeline for antibody modeling and design
|
|
EP3623382A1
(en)
|
2018-09-14 |
2020-03-18 |
Universität Zürich |
Ligands to gm-csf or gm-csf-receptor for use in leukemia in a patient having undergone allo-hct
|
|
US11655293B2
(en)
|
2018-02-22 |
2023-05-23 |
Universitat Zurich |
Ligands to GM-CSF or GM-CSF-receptor for use in leukemia in a patient having undergone allo-HCT
|
|
CA3094176A1
(en)
|
2018-03-22 |
2019-09-26 |
Charite-Universitatsmedizin Berlin |
Crispr associated protein reactive t cell immunity
|
|
WO2019238966A1
(en)
|
2018-06-15 |
2019-12-19 |
Universität Bern |
LIGANDS TO LIGHT OR ITS RECEPTOR LTßR FOR USE IN HAEMATOLOGIC MALIGNANCIES
|
|
KR20210075080A
(ko)
|
2018-10-08 |
2021-06-22 |
유니베르시태트 취리히 |
Her2-결합 사량체 폴리펩티드
|
|
WO2020104627A1
(en)
|
2018-11-21 |
2020-05-28 |
Universität Zürich |
Photochemically induced conjugation of radiometals to small molecules, peptides and nanoparticles in a simultaneous one-pot reaction
|
|
EP3677911A3
(en)
|
2019-01-03 |
2020-07-29 |
Universität Basel |
Use of non-agonist ligands for suppression of metastasis
|
|
WO2020144378A1
(en)
|
2019-01-11 |
2020-07-16 |
Universitätsspital Basel |
Sglt-2 inhibitors or il-1r antagonists for reduction of hypoglycaemia after bariatric surgery
|
|
EP3930687A4
(en)
|
2019-02-25 |
2023-06-07 |
The University of Chicago |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS USING ECM AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS
|
|
EP3953712A1
(en)
|
2019-04-10 |
2022-02-16 |
Universität Zürich |
A method for determining the likelihood of a patient being responsive to cancer immunotherapy
|
|
KR20220016944A
(ko)
*
|
2019-06-04 |
2022-02-10 |
몰리큘라 파트너스 아게 |
개선된 안정성을 갖는 설계된 안키린 반복 도메인
|
|
CA3139164A1
(en)
*
|
2019-06-04 |
2020-12-10 |
Molecular Partners Ag |
Recombinant fap binding proteins and their use
|
|
JP2022535564A
(ja)
|
2019-06-04 |
2022-08-09 |
モレキュラー パートナーズ アクチェンゲゼルシャフト |
多選択性タンパク質
|
|
EP4025693A1
(en)
|
2019-09-05 |
2022-07-13 |
Genome Biologics UG |
Inhibition of mthfd1l for use in hypertrophic heart disease and heart failure
|
|
AU2020402581A1
(en)
|
2019-12-11 |
2022-06-23 |
Molecular Partners Ag |
Designed ankyrin repeat domains with altered surface residues
|
|
CN114945584A
(zh)
|
2019-12-11 |
2022-08-26 |
分子合作伙伴股份公司 |
重组肽-mhc复合物结合蛋白及其生成和用途
|
|
WO2021122813A1
(en)
|
2019-12-16 |
2021-06-24 |
Universität Basel |
Angiogenesis promoting agents for prevention of metastatic cancer
|
|
WO2021176008A1
(en)
|
2020-03-04 |
2021-09-10 |
Cornell University |
Agents targeting baf155 or brg1 for use in treatment of advanced prostate cancer
|
|
EP4132578A1
(en)
|
2020-04-06 |
2023-02-15 |
Universität Zürich |
Artc1 ligands for cancer treatment
|
|
MX2022013945A
(es)
|
2020-05-06 |
2023-02-14 |
Molecular Partners Ag |
Nuevas proteinas de union a repeticiones de anquirina y sus usos.
|
|
AU2021271131A1
(en)
*
|
2020-05-14 |
2022-12-15 |
Molecular Partners Ag |
Recombinant CD40 binding proteins and their use
|
|
IL298168A
(en)
*
|
2020-05-14 |
2023-01-01 |
Molecular Partners Ag |
Multispecific proteins
|
|
JP2023504675A
(ja)
|
2020-05-19 |
2023-02-06 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ガンの処置のための結合分子
|
|
WO2021239844A1
(en)
|
2020-05-27 |
2021-12-02 |
Universitätsspital Basel |
Sglt-2 inhibitors or il-1r antagonists for reduction of hypoglycaemia in prediabetes
|
|
WO2021239999A1
(en)
|
2020-05-28 |
2021-12-02 |
Universität Zürich |
Il-12 pd-l1 ligand fusion protein
|
|
US11981710B2
(en)
*
|
2020-08-18 |
2024-05-14 |
Athebio Ag |
N-terminal capping modules of ankyrin repeat domains
|
|
EP3957649A1
(en)
|
2020-08-18 |
2022-02-23 |
Athebio AG |
Improved n-terminal capping modules of ankyrin repeat domains
|
|
US12692306B2
(en)
|
2020-08-18 |
2026-07-28 |
Universität Zürich |
CD25-biased anti-IL-2 antibody
|
|
CN114106194B
(zh)
*
|
2020-08-31 |
2024-01-16 |
中国科学院天津工业生物技术研究所 |
一种用于治疗糖尿病和/或肥胖症的融合蛋白
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
US20240108746A1
(en)
|
2020-12-16 |
2024-04-04 |
Molecular Partners Ag |
Novel slow-release prodrugs
|
|
AU2021403658A1
(en)
|
2020-12-16 |
2023-06-29 |
Molecular Partners Ag |
Recombinant cd3 binding proteins and their use
|
|
US20240310378A1
(en)
|
2021-02-11 |
2024-09-19 |
Universität Zürich |
Use of markers found on lymph node metastatic samples for the prognosis of breast cancer
|
|
EP4043481A1
(en)
*
|
2021-02-15 |
2022-08-17 |
Affilogic |
Compounds and methods for extending half life of biomolecules
|
|
WO2022190016A1
(en)
|
2021-03-09 |
2022-09-15 |
Molecular Partners Ag |
Novel darpin based multi-specific t-cell engagers
|
|
EP4305063A1
(en)
|
2021-03-09 |
2024-01-17 |
Molecular Partners AG |
Protease cleavable prodrugs
|
|
CA3211368A1
(en)
|
2021-03-09 |
2022-09-15 |
Molecular Partners Ag |
Novel darpin based cd123 engagers
|
|
US20240317852A1
(en)
|
2021-03-09 |
2024-09-26 |
Molecular Partners Ag |
Novel darpin based cd33 engagers
|
|
KR20230169182A
(ko)
*
|
2021-04-09 |
2023-12-15 |
몰리큘라 파트너스 아게 |
신규한 DARPin 기반 CD70 인게이저
|
|
IL310612A
(en)
|
2021-08-05 |
2024-04-01 |
Immunos Therapeutics Ag |
HLA-B57 is different with increased expression levels
|
|
MX2024001691A
(es)
|
2021-08-05 |
2024-04-19 |
Immunos Therapeutics Ag |
Medicamentos de combinación que comprenden proteínas de fusión de antígeno leucocitario de humano (hla).
|
|
WO2023021006A1
(en)
|
2021-08-16 |
2023-02-23 |
Universität Zürich |
Il-1 targeting agents for treatment of pitiyriasis rubra pilaris
|
|
EP4137508A1
(en)
|
2021-08-17 |
2023-02-22 |
Athebio AG |
Variants of ankyrin repeat domains
|
|
WO2023021050A1
(en)
|
2021-08-17 |
2023-02-23 |
Athebio Ag |
Variants of ankyrin repeat domains
|
|
WO2023036849A1
(en)
|
2021-09-07 |
2023-03-16 |
ETH Zürich |
Identifying and predicting future coronavirus variants
|
|
EP4163380A1
(en)
|
2021-10-08 |
2023-04-12 |
ETH Zurich |
Device and method for manipulation of extracellular vesicles
|
|
WO2023110942A1
(en)
|
2021-12-14 |
2023-06-22 |
Charité-Universitätsmedizin Berlin |
Prevention of impaired fracture healing
|
|
WO2023110983A1
(en)
|
2021-12-14 |
2023-06-22 |
Molecular Partners Ag |
Designed repeat domains with dual binding specificity and their use
|
|
EP4260907A1
(en)
|
2022-04-11 |
2023-10-18 |
Universität Zürich |
Agents for treatment of endometriosis and other benign gynecological neoplasms
|
|
WO2024002914A1
(en)
|
2022-06-27 |
2024-01-04 |
Charité-Universitätsmedizin Berlin |
Prediction of, and composition to improve, tendon healing
|
|
CA3262553A1
(en)
|
2022-08-01 |
2024-02-08 |
Molecular Partners Ag |
REHEARSAL AREAS DESIGNED WITH MODIFIED CHARGES AND THEIR USE
|
|
EP4573106A2
(en)
|
2022-08-16 |
2025-06-25 |
Athebio AG |
Variants of ankyrin repeat domains
|
|
WO2024037743A1
(en)
|
2022-08-16 |
2024-02-22 |
Athebio Ag |
Variants of ankyrin repeat domains
|
|
WO2024038307A1
(en)
|
2022-08-19 |
2024-02-22 |
Novartis Ag |
Dosing regimens for sars-cov-2 binding molecules
|
|
WO2024064200A2
(en)
*
|
2022-09-20 |
2024-03-28 |
The Texas A&M University System |
Darpin-containing compositions and methods thereof
|
|
EP4638473A1
(en)
|
2022-12-19 |
2025-10-29 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Means and methods to target endogenous condensates
|
|
JP2026514293A
(ja)
|
2023-02-08 |
2026-05-08 |
イムノス セラピューティクス アーゲー |
β２ミクログロブリン、ＨＬＡ重鎖ポリペプチド及びＣＤ４７－ＳＩＲＰαの阻害剤の融合タンパク質
|
|
IL322519A
(en)
|
2023-02-17 |
2025-10-01 |
Ablynx Nv |
Polypeptides that bind to the neonatal fc receptor
|
|
EP4673159A1
(en)
|
2023-02-27 |
2026-01-07 |
Molecular Partners AG |
Darpins for use in reducing renal accumulation of drugs
|
|
EP4724473A1
(en)
|
2023-06-06 |
2026-04-15 |
Molecular Partners AG |
Recombinant cd47 binding proteins and their use
|
|
JP2026524079A
(ja)
|
2023-06-06 |
2026-07-17 |
モレキュラー パートナーズ アクチェンゲゼルシャフト |
組換えｃｄ２結合タンパク質及びその使用
|
|
WO2024251628A1
(en)
|
2023-06-06 |
2024-12-12 |
Molecular Partners Ag |
Recombinant cd16a binding proteins and their use
|
|
WO2025008519A1
(en)
|
2023-07-05 |
2025-01-09 |
Universität Bern |
Il-1ra blockers for treatment and prevention of sepsis
|
|
WO2025021293A1
(en)
|
2023-07-25 |
2025-01-30 |
Universität Zürich |
Disruption of rbr1 expression in plant cells
|
|
WO2025146491A1
(en)
|
2024-01-05 |
2025-07-10 |
Molecular Partners Ag |
Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent
|
|
WO2025146490A1
(en)
|
2024-01-05 |
2025-07-10 |
Molecular Partners Ag |
Recombinant cd117 binding proteins and their use
|
|
CN122438868A
(zh)
|
2024-01-05 |
2026-07-21 |
分子合作伙伴股份公司 |
多特异性结合蛋白
|
|
WO2025163144A1
(en)
|
2024-01-31 |
2025-08-07 |
Molecular Partners Ag |
Recombinant mesothelin binding proteins and their use
|
|
WO2025163082A1
(en)
|
2024-01-31 |
2025-08-07 |
Molecular Partners Ag |
Dll3-specific binding constructs and their use in radiotherapy
|
|
WO2025202503A1
(en)
|
2024-03-28 |
2025-10-02 |
Universität Zürich |
Extracellular vesicles carrying cancer specific splice variants
|
|
WO2026093563A2
(en)
|
2024-10-31 |
2026-05-07 |
Molecular Partners Ag |
Multispecific binding proteins and their use
|
|
WO2026150109A1
(en)
|
2025-01-10 |
2026-07-16 |
Molecular Partners Ag |
Mesothelin-specific binding constructs and their use in radiotherapy
|